Briefs

NEW YORK, April 21 (GenomeWeb News) - the US Food and Drug Administration is soliciting gene expression datasets from microarray experiments as part of its MicroArray Quality Control (MAQC) posted on the FDA website, FDA said that it is seeking datasets "as well as proposals to analyze these datasets in order to evaluate the impact of different analysis protocols on the selection of genes and their associated signatures for biomarker pattern development."

The FDA's National Center for Toxicological Research is collecting the datasets and proposals for participation in the project. The evaluation process is open to the public, FDA said.

The MAQC project involves six FDA centers, several microarray vendors, government agencies, and academic labs that are working to develop "baseline practices for the analysis of hybridization data," the FDA said.